Evidence map›Paper›PMID 20011115›Full record

ArticlePLoS pathogens2009

CD14 signaling restrains chronic inflammation through induction of p38-MAPK/SOCS-dependent tolerance.

Bikash Sahay, Rebeca L Patsey, Christian H Eggers, Juan C Salazar, Justin D Radolf, Timothy J Sellati

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 56 citations in OpenAlex.

  1. Antiviral Role of Surface Layer Protein A (SlpA) ofPathogens (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Protection againstHuman vaccines & immunotherapeutics · 2020
    Article
  8. Review
  9. Article
  10. Article
  11. Marine drugs · 2018
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Lyme borreliosis.Nature reviews. Disease primers · 2016
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Bikash SahayCenter for Immunology and Microbial Disease, Albany Medical College, Albany, New York, USA.
Rebeca L Patsey
Christian H Eggers
Juan C Salazar
Justin D Radolf
Timothy J Sellati
Albany Medical Center Hospital · USUConn Health · USConnecticut Children's Medical Center · US

Funding

RpoS Regulation of Borrelia burgdorferi Genes in vivoR01AI029735 · NIAID · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI CAIMANO, MELISSA J, RADOLF, JUSTIN D · 1990 to 2022
$10.7M
CUTANEOUS IMMUNE RESPONSE IN SECONDARY SYPHILISR01AI038894 · NIAID · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI RADOLF, JUSTIN D · 1996 to 2005
$2.1M
CD14 AND THE IMMUNOPATHOGENESIS OF CHRONIC LYME DISEASER01AI054546 · NIAID · ALBANY MEDICAL COLLEGE · PI SELLATI, TIMOTHY J · 2004 to 2008
$1.7M
Modulating MMP-9 and Neutrophil Recruitment: A Therapeutic Strategy for TularemiaR01AI075193 · NIAID · ALBANY MEDICAL COLLEGE · PI SELLATI, TIMOTHY J · 2008 to 2011
$1.5M
RpoS Regulation of Borrelia burgdorferi Genes in vivoR56AI029735 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI RADOLF, JUSTIN D · 2012 to 2012
$536k
Immunity in Early Syphillis: Pathway to HIV CoinfectionK23AI062439 · NIAID · CONNECTICUT CHILDREN'S MEDICAL CENTER · PI SALAZAR, JUAN C · 2005 to 2007
$454k
NIAID NIH HHS K23 AI062439NIAID NIH HHS R01 AI029735NIAID NIH HHS R01 AI038894NIAID NIH HHS R01 AI054546NIAID NIH HHS R01 AI075193NIAID NIH HHS R56 AI029735
6 · The paper itself

Abstract

Current thinking emphasizes the primacy of CD14 in facilitating recognition of microbes by certain TLRs to initiate pro-inflammatory signaling events and the importance of p38-MAPK in augmenting such responses. Herein, this paradigm is challenged by demonstrating that recognition of live Borrelia burgdorferi not only triggers an inflammatory response in the absence of CD14, but one that is, in part, a consequence of altered PI3K/AKT/p38-MAPK signaling and impaired negative regulation of TLR2. CD14 deficiency results in increased localization of PI3K to lipid rafts, hyperphosphorylation of AKT, and reduced activation of p38. Such aberrant signaling leads to decreased negative regulation by SOCS1, SOCS3, and CIS, thereby compromising the induction of tolerance in macrophages and engendering more severe and persistent inflammatory responses to B. burgdorferi. Importantly, these altered signaling events and the higher cytokine production observed can be mimicked through shRNA and pharmacological inhibition of p38 activity in CD14-expressing macrophages. Perturbation of this CD14/p38-MAPK-dependent immune regulation may underlie development of infectious chronic inflammatory syndromes.

Indexed as

AnimalsBlotting, WesternBorrelia burgdorferiBorrelia InfectionsCell SeparationChronic DiseaseFlow CytometryGene ExpressionGene Expression RegulationImmune ToleranceInflammationLipopolysaccharide ReceptorsMacrophage ActivationMacrophagesMiceMice, KnockoutLipopolysaccharide ReceptorsNF-kappa Bp38 Mitogen-Activated Protein KinasesSuppressor of Cytokine Signaling ProteinsToll-Like Receptor 2

Identifiers

PMID20011115
PMCPMC2781632
OpenAlexW2052621996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.